APA (7th ed.) Citation

JF, C., CS, P., SM, C., JP, G., Z, S., B, B., . . . MM, S. (2026). CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions. Molecular medicine (Cambridge, Mass.), 32(1), . https://doi.org/10.1186/s10020-026-01462-z

Chicago Style (17th ed.) Citation

JF, Cohen-Solal, et al. "CD64 Binding Potential Does Not Translate into Enhanced Therapeutic Efficacy for Anti-IL-23 Antibodies Under Physiologically Relevant Conditions." Molecular Medicine (Cambridge, Mass.) 32, no. 1 (2026). https://doi.org/10.1186/s10020-026-01462-z.

MLA (9th ed.) Citation

JF, Cohen-Solal, et al. "CD64 Binding Potential Does Not Translate into Enhanced Therapeutic Efficacy for Anti-IL-23 Antibodies Under Physiologically Relevant Conditions." Molecular Medicine (Cambridge, Mass.), vol. 32, no. 1, 2026, https://doi.org/10.1186/s10020-026-01462-z.